CCR5 and breast carcinoma: Linked to in vivo literature, a CCR5−/− mouse model on the background of the spontaneous mammary carcinoma model (mammary tumor virus—polyoma middle T antigen (MMTV-PyMT)), significantly delayed the crucial early stages of invasive tumor development [29].